Login
Israel-Hamas Conflict
World Cup
Benjamin Netanyahu
Social Media
Boxing
Military
Donald Trump
Soccer
Instagram
Cryptocurrency
Natural Disasters
Music
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

medwirenews.com image

News from medwirenews.com

We’ve assigned a media bias rating of unknown to medwirenews.com. You can read more about our methodology here.

Information about medwirenews.com

Where is medwirenews.com located?medwirenews.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top medwirenews.com News

Support for amiloride as a spironolactone alternative in resistant hypertension
Suresnes · Suresnes

Support for amiloride as a spironolactone alternative in resistant hypertension

By Lucy Piper, medwireNews ReportermedwireNews: The diuretic amiloride may be a suitable treatment alternative to spironolactone for patients with resistant hypertension, suggests a study published in JAMA.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © Alessandro Grandini / stock.adobe.com The post Support for amilori…Read Article
Childhood cancer survivors might benefit from cochlear implants
Suresnes · Suresnes

Childhood cancer survivors might benefit from cochlear implants

By Lynda Williams, medwireNews ReportermedwireNews: Childhood cancer survivors with severe to profound sensorineural hearing loss following chemotherapy or radiotherapy may be candidates for cochlear implants, US researchers believe.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © Sladic / Getty Images / iStock The post…Read Article

Resistant Hypertension: Diagnosis and Real-World Challenges

Explore the complexities of resistant hypertension, its causes, and effective treatment strategies to achieve better blood pressure control.HealthSee the Story

Polygenic risk score may improve prostate cancer screening

medwireNews: A polygenic risk score could help direct prostate cancer screening towards those at highest risk for the disease, the BARCODE1 investigators report.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © angellodeco / stock.adobe.com The post Polygenic risk score may improve prostate cancer screening appeared firs…Suresnes · SuresnesRead Article

Intensive systolic blood pressure control reduces CVD mortality risk in the over 80s

By Lucy Piper, medwireNews ReportermedwireNews: Antihypertensive treatment of patients over the age of 80 years to a target systolic blood pressure below 130 mmHg could significantly reduce their risk of death from cardiovascular disease by 26%, suggests an analysis of NHANES data.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage …Suresnes · SuresnesRead Article

Half-dose apixaban noninferior for preventing recurrent VTE in cancer patients

By Lynda Williams, medwireNews ReportermedwireNews: For patients with active cancer and venous thromboembolism, a reduced dose of apixaban is noninferior to the standard dose for preventing recurrent thromboembolic episodes and significantly reduces the risk of clinically relevant bleeding, report the API-CAT investigators.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full st…Cancer · SuresnesRead Article

‘Accelerated’ onset of aging-related disease highlighted for childhood cancer survivors

By Lynda Williams, medwireNews ReportermedwireNews: Children who survive for at least 5 years after treatment for cancer are 2.7 times more likely to develop one of eight aging-related chronic health conditions before the age of 65 years than members of the general population, US researchers suggest.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Se…CancerSee the Story

Mixed results for tetramethylpyrazine nitrone treatment in ALS

By Lucy Piper, medwireNews ReportermedwireNews: Tetramethylpyrazine nitrone does not slow overall functional decline in patients with amyotrophic lateral sclerosis, but it may help retain grip strength and is well tolerated, suggest study findings.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © JuanCi Studio / stock.ad…Suresnes · SuresnesRead Article

Vaccine may improve breast cancer treatment outcomes

100% Center coverage: 1 sources
Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a recent pilot study. The study combined the HER2-targeting dendritic cell vaccines with standard chemotherapy, demonstrating both safety and positive …CancerSee the Story

You've scrolled to the bottom of the feed, there are no more stories.

Breaking News Topics Related to medwirenews.com

Suresnes

Suresnes

Cancer

Cancer

Tlaxcala

Tlaxcala

Île-De-France

Île-De-France

France

France

Hauts-De-Seine

Hauts-De-Seine

News
For You
SearchBlindspotLocal